patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
ansuvimab
Marketedupdated 2mo agoby Ridgeback Biotherapeutics LLC
Approvedcommunity read0 votes
all catalysts(5)
approval · 5
Dec 21, 2020
approval
EBANGA (ANSUVIMAB-ZYKL) — FDA approval
ansuvimab
→
Dec 7, 2021
approval
EBANGA (ANSUVIMAB-ZYKL) — FDA approval
ansuvimab
→
May 19, 2022
approval
EBANGA (ANSUVIMAB-ZYKL) — FDA approval
ansuvimab
→
Dec 26, 2024
approval
EBANGA (ANSUVIMAB-ZYKL) — FDA approval
ansuvimab
→
Feb 18, 2026
approval
EBANGA (ANSUVIMAB-ZYKL) — FDA approval
ansuvimab
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that